Filter
2455
Filtered Results: 2455
Text search:
ART
drugs
Featured
Recommendations
193
New Publications
745
Language
Document type
No document type
1798
Studies & Reports
235
Guidelines
219
Manuals
79
Strategic & Response Plan
34
Training Material
32
Fact sheets
30
Infographics
12
Situation Updates
9
Brochures
4
Resource Platforms
3
Countries / Regions
India
150
Kenya
91
South Africa
76
Zambia
69
Tanzania
65
Ethiopia
61
Malawi
59
Nigeria
52
Uganda
49
Western and Central Europe
48
Nepal
46
Rwanda
42
Liberia
38
Myanmar / Burma
38
Lesotho
35
Ghana
35
Global
35
Namibia
35
Ukraine
31
Africa
31
Bangladesh
28
Sierra Leone
27
Zimbabwe
25
Asia
25
Eastern Europe
25
Latin America and the Carribbean
22
Cambodia
21
Botswana
20
Senegal
17
Germany
17
Philippines
16
Indonesia
15
Mozambique
14
South–East Asia Region
14
Eswatini/ Swaziland
14
Albania
11
Venezuela
10
Brazil
10
Russia
10
Congo, Democratic Republic of
9
Cameroon
8
Tajikistan
7
Syria
7
Colombia
6
Burkina Faso
6
Haiti
6
Paraguay
6
Georgia
6
Pakistan
6
Thailand
5
East and Southern Africa
5
Yemen
5
South Sudan
5
Benin
4
Afghanistan
4
Guinea
4
Armenia
4
West and Central Africa
4
Middle East and North Africa
4
Argentina
4
Romania
4
Estonia
3
USA
3
Eastern Europe and Central Asia
3
Vietnam
3
Moldova
3
Sudan
3
Central African Republic
3
Bhutan
3
North Macedonia
2
Timor Leste/ East Timor
2
Serbia
2
China
2
Uzbekistan
2
Peru
2
Western Pacific Region
2
Bolivia
2
Lebanon
2
Papua New Guinea
2
Sri Lanka
2
Palestine
2
Poland
2
Somalia
2
Ecuador
2
North Korea
1
Switzerland
1
Mexico
1
El Salvador
1
Australia
1
Gambia
1
Chile
1
Iran
1
Canada
1
Laos
1
Niger
1
Burundi
1
Qatar
1
Bulgaria
1
Hungary
1
Lithuania
1
Jordan
1
Saudi Arabia
1
Uruguay
1
Turkmenistan
1
Belarus
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Djibouti
1
Egypt
1
Greece
1
Mali
1
Libya
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1102
Clinical Guidelines
192
Women & Child Health
83
Public Health
66
Capacity Building
56
Key Resources
38
Pharmacy & Technologies
20
Annual Report MEDBOX
2
Toolboxes
HIV
587
TB
273
Mental Health
147
COVID-19
47
Pharmacy
47
Caregiver
45
Refugee
33
Disability
28
AMR
27
NTDs
26
Global Health Education
20
Conflict
19
Rapid Response
16
Planetary Health
15
Ebola
12
NCDs
12
Natural Hazards
10
Health Financing Toolbox
10
Social Ethics
9
Specific Hazards
4
Polio
4
Cholera
3
Zika
2
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
TB heroes
Hello, my name is Nurse X
My job is to promote integrated HIV and TB prevention, care, treatment and support. This ensures that we, and my team of health care service providers treat everyone who is living with HIV and TB to have all the antiretroviral therapy (ART) and HIV care services...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a...
WHO recommends that a...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
Due to the anticipated significant rise in VL testing occasioned by Ghana’s adaptation of 2016 ART guidelines, it has become necessary to develop this VL scale-up and operational plan to assure complete client access to laboratory monitoring towards the achievement of the third 90 of the HIV care ...
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
In line with its decentralization principle, the Ethiopian Health Policy has achieved great progress in improving access to comprehensive HIV/AIDS services to the majority of the population. Both quality and coverage of services have improved significantlysince the initiation...
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure prophylaxis (PEP) with highly active antiretroviral trea...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggested techniques described in this handbook are helpfu...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
The uneven distribution of HIV risks and burdens across populations is a well-substantiated fact, though seldom publicly acknowledged. Gay men and other men who have sex with men, people who inject drugs, sex workers, and transgender women are 24, 24, 13.5, and 49 times more likely to acquire HIV, ...
In 2014, GHS/NACP, with support from UNICEF and other partners, conducted a situation analysis on paediatric HIV care and treatment in Ghana. The purpose of this analysis was to identify the gaps within the current delivery of paediatric HIV care and support system and develop a road map for effecti...
Journal of the International AIDS Society 2016, 19:20926
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ...
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ...
